Study assesses impact of SARS-CoV-2 omicron subvariant BA.2.86’s multiple mutations

A combined team of medical researchers from Columbia University and the University of Michigan has found that, despite multiple mutations, the SARS-CoV-2 omicron subvariant BA.2.86 does not appear to be more dangerous than prior subvariants. In their paper published in the journal Nature, the group describes the multiple ways they tested the new subvariant and what they found by doing so.